{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-22-005330","form_type":"8-K","ticker":"PRCT","cik":"0001588978","company_name":"PROCEPT BioRobotics Corp","filed_at":"2022-03-08T23:59:59+00:00","discovered_at":"2026-05-14T18:04:07.231548+00:00","generated_at":"2026-06-27T00:45:54.547281+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"PROCEPT BioRobotics Q4 revenue $10.1M (+216% YoY); guides FY2022 revenue $54-58M","bullets":["Revenue $10.1M in Q4 2021, up from $3.2M YoY; full year $34.5M vs $7.7M.","U.S. system/rental revenue $5.0M (Q4) vs $1.2M; handpiece/consumables $3.4M vs $0.8M.","Net loss widened to $18.3M in Q4 from $15.3M; full year loss $59.9M vs $53.0M.","Guides Q1 2022 revenue $12-12.5M; FY2022 revenue $54-58M, gross margin 47-49%, adj. EBITDA loss $60-63M.","Positive 5-year WATER Study data announced Feb 2022; sales force doubled."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-22-005330","json":"https://secwatch.observer/filing/0001628280-22-005330.json","markdown":"https://secwatch.observer/filing/0001628280-22-005330.md","text":"https://secwatch.observer/filing/0001628280-22-005330.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1588978/000162828022005330/0001628280-22-005330-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1588978/000162828022005330/prct-20220308.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T00:45:54.547281+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}